Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |